About a quarter (27%) of GLP-1 users report having insurance but paying the whole cost of the medication themselves
It is supported by Dezan Shira & Associates , a pan-Asia, multi-disciplinary professional services firm that assists foreign investors throughout Asia, including through offices in Delhi , Mumbai , and Bengaluru in India
The FDA approval of Rezdiffra, the first NASH medication, serves as a significant boost for the market, offering fresh hope to countless patients
Early evidence suggests that this approach may translate into greater average weight loss and stronger improvements in blood-sugar control, though both medicines have proven benefits when used correctly within NHS guidelines.
however, there was a small increase in CTX [MD: +0.04 g/L (95% CI: 0.01 to 0.07)] ( Weight loss attributable to the GLP1Ra interventions included in the meta-analysis by Kim et al
Regular follow-up appointments with healthcare providers can also support adherence by addressing any concerns or challenges patients may face